Welcome to Avipep
Avipep Pty Ltd is a privately owned company based in Melbourne Australia.
Avipep is focused on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. Avibodies consist of the key binding domains of an antibody thereby sharing the same selectivity and avidity for its target. Clinical data suggests that a greater proportion of an injected dose of an Avibody is deposited in the tumour when compared to whole antibodies with potential advantages in terms of efficacy and safety. Different payloads can be conjugated to specifically engineered sites on Avibodies producing homogeneous products for radio-immunotherapy (RIT), ADC drug therapy, molecular imaging or for the creation of immuno-conjugates and bi-specifics.